Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease

被引:133
|
作者
Rothnie, Kieran J. [1 ,2 ]
Muellerova, Hana [3 ]
Smeeth, Liam [2 ]
Quint, Jennifer K. [1 ,2 ]
机构
[1] Imperial Coll London, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, Emmanuel Kaye Bldg, London SW3 6LR, England
[2] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England
[3] GlaxoSmithKline R&D, Resp Epidemiol, Uxbridge, Middx, England
关键词
epidemiology; cohort studies; case-control studies; COPD; FREQUENCY; CARE;
D O I
10.1164/rccm.201710-2029OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) are important adverse events in the natural history of chronic obstructive pulmonary disease (COPD). Objectives: To investigate the natural history of AECOPDs over 10 years of follow-up. Methods: We identified 99,574 patients with COPD from January 1, 2004, toMarch 31, 2015, from the UK Clinical Practice Research Datalink. We defined moderate AECOPDs as those managed outside hospital and severe as those requiring hospitalization. During the baseline period (first year of follow-up), patients were grouped according to the number and severity of AECOPDs and then followed for a maximum of 10 years (mean, 4.9 yr). We investigated the effect of baseline AECOPD number and severity on risk of further events and death. Measurements and Main Results: Around one-quarter of the patients with COPD did not exacerbate during follow-up. Compared with no AECOPDs in the baseline period, AECOPD number predicted the future long-term rate of AECOPDs in a graduated fashion, ranging from hazard ratio (HR) of 1.71 (1.66-1.77) for one event to HR of 3.41 (3.27-3.56) for five or more events. Two or more moderate AECOPDs were also associated with an increased risk of death in a graduated fashion, ranging from HR of 1.10 (1.03-1.18) for two moderate AECOPDs to HR of 1.57 (1.45-1.70) for five or more moderate AECOPDs, compared with those with no AECOPDs at baseline. Severe AECOPDs were associated with an even higher risk of death (HR, 1.79; 1.65-1.94). Conclusions: A large proportion of patients with COPD do not exacerbate over amaximum 10 years of follow-up. AECOPD frequency in a single year predicts long-term AECOPD rate. Increasing frequency and severity of AECOPDs is associated with risk of death and highlights the importance of preventing AECOPDs.
引用
收藏
页码:464 / 471
页数:8
相关论文
共 50 条
  • [1] Chronic obstructive pulmonary disease .6: The aetiology of exacerbations of chronic obstructive pulmonary disease
    White, AJ
    Gompertz, S
    Stockley, RA
    [J]. THORAX, 2003, 58 (01) : 73 - 80
  • [2] Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice
    Miravitlles, M
    Mayordomo, C
    Artés, M
    Sánchez-Agudo, L
    Nicolau, F
    Segú, JL
    [J]. RESPIRATORY MEDICINE, 1999, 93 (03) : 173 - 179
  • [3] The role played by exacerbations in the natural history of chronic obstructive pulmonary disease
    Soler Cataluna, Juan Jose
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2007, 43 (02): : 55 - 58
  • [4] Natural history of exacerbations in patients with chronic obstructive pulmonary disease.
    Donaldson, GC
    Seemungal, TAR
    Wedzicha, JA
    [J]. THORAX, 2000, 55 : A3 - A3
  • [5] Chronic Obstructive Pulmonary Disease Exacerbations
    Gaga, M.
    [J]. EUROPEAN RESPIRATORY REVIEW, 2009, 18 (114): : 305 - 305
  • [6] Exacerbations of chronic obstructive pulmonary disease
    Kidney, J
    McManus, T
    Coyle, PV
    [J]. THORAX, 2002, 57 (09) : 753 - 754
  • [7] Exacerbations of chronic obstructive pulmonary disease
    Celli, B. R.
    Barnes, P. J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (06) : 1224 - 1238
  • [8] Pulmonary embolism and exacerbations of chronic obstructive pulmonary disease
    Mispelaere, D
    Glerant, JC
    Audebert, M
    Remond, A
    Sevestre-Pietri, MA
    Jounieaux, V
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2002, 19 (04) : 415 - 423
  • [9] The global burden of chronic obstructive pulmonary disease, number 3, The natural history of chronic obstructive pulmonary disease
    Mannino, DM
    Watt, G
    Hole, D
    Gillis, C
    Hart, C
    McConnachie, A
    Smith, GD
    Upton, M
    Hawthorne, V
    Sin, DD
    Man, SFP
    Van Eeden, S
    Mapel, DW
    Vestbo, J
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (03) : 627 - 643
  • [10] Antibiotics for exacerbations of chronic obstructive pulmonary disease
    Vollenweider, Daniela J.
    Frei, Anja
    Steurer-Stey, Claudia A.
    Garcia-Aymerich, Judith
    Puhan, Milo A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10):